122 related articles for article (PubMed ID: 29574240)
1. Heterocyclic organobismuth (III) compounds containing an eight-membered ring: Inhibitory effects on cell cycle progression.
Iuchi K; Yagura T
Toxicol In Vitro; 2018 Aug; 50():172-178. PubMed ID: 29574240
[TBL] [Abstract][Full Text] [Related]
2. Heterocyclic organobismuth(III) compound targets tubulin to induce G2/M arrest in HeLa cells.
Iuchi K; Akagi K; Yagura T
J Pharmacol Sci; 2009 Apr; 109(4):573-82. PubMed ID: 19352070
[TBL] [Abstract][Full Text] [Related]
3. Heterocyclic organobismuth(III) compound induces nonapoptotic cell death via lipid peroxidation.
Iuchi K; Shirai S; Tasaki Y; Hisatomi H
Anticancer Drugs; 2020 Jan; 31(1):55-59. PubMed ID: 31609767
[TBL] [Abstract][Full Text] [Related]
4. Heterocyclic organobismuth(III) induces apoptosis of human promyelocytic leukemic cells through activation of caspases and mitochondrial perturbation.
Iuchi K; Hatano Y; Yagura T
Biochem Pharmacol; 2008 Oct; 76(8):974-86. PubMed ID: 18760261
[TBL] [Abstract][Full Text] [Related]
5. Leiodermatolide, a novel marine natural product, has potent cytotoxic and antimitotic activity against cancer cells, appears to affect microtubule dynamics, and exhibits antitumor activity.
Guzmán EA; Xu Q; Pitts TP; Mitsuhashi KO; Baker C; Linley PA; Oestreicher J; Tendyke K; Winder PL; Suh EM; Wright AE
Int J Cancer; 2016 Nov; 139(9):2116-26. PubMed ID: 27376928
[TBL] [Abstract][Full Text] [Related]
6. FR901228 causes mitotic arrest but does not alter microtubule polymerization.
Sandor V; Robbins AR; Robey R; Myers T; Sausville E; Bates SE; Sackett DL
Anticancer Drugs; 2000 Jul; 11(6):445-54. PubMed ID: 11001385
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial properties of some cyclic organobismuth(III) compounds.
Kotani T; Nagai D; Asahi K; Suzuki H; Yamao F; Kataoka N; Yagura T
Antimicrob Agents Chemother; 2005 Jul; 49(7):2729-34. PubMed ID: 15980343
[TBL] [Abstract][Full Text] [Related]
8. Studies on the cytotoxicity and anticancer performance of heterocyclic hypervalent organobismuth(III) compounds.
Liu YP; Lei J; Tang LW; Peng Y; Au CT; Chen Y; Yin SF
Eur J Med Chem; 2017 Oct; 139():826-835. PubMed ID: 28865278
[TBL] [Abstract][Full Text] [Related]
9. Novel benzylidene-9(10H)-anthracenones as highly active antimicrotubule agents. Synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
Prinz H; Ishii Y; Hirano T; Stoiber T; Camacho Gomez JA; Schmidt P; Düssmann H; Burger AM; Prehn JH; Günther EG; Unger E; Umezawa K
J Med Chem; 2003 Jul; 46(15):3382-94. PubMed ID: 12852768
[TBL] [Abstract][Full Text] [Related]
10. Antimitotic sulfonamides inhibit microtubule assembly dynamics and cancer cell proliferation.
Mohan R; Banerjee M; Ray A; Manna T; Wilson L; Owa T; Bhattacharyya B; Panda D
Biochemistry; 2006 May; 45(17):5440-9. PubMed ID: 16634625
[TBL] [Abstract][Full Text] [Related]
11. The small molecule CS1 inhibits mitosis and sister chromatid resolution in HeLa cells.
Wu X; Li Z; Shen Y
Biochim Biophys Acta Gen Subj; 2018 May; 1862(5):1134-1147. PubMed ID: 29410075
[TBL] [Abstract][Full Text] [Related]
12. The cytotoxicity of organobismuth compounds with certain molecular structures can be diminished by replacing the bismuth atom with an antimony atom in the molecules.
Kohri K; Yoshida E; Yasuike S; Fujie T; Yamamoto C; Kaji T
J Toxicol Sci; 2015 Jun; 40(3):321-7. PubMed ID: 25972193
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents.
Stefański T; Mikstacka R; Kurczab R; Dutkiewicz Z; Kucińska M; Murias M; Zielińska-Przyjemska M; Cichocki M; Teubert A; Kaczmarek M; Hogendorf A; Sobiak S
Eur J Med Chem; 2018 Jan; 144():797-816. PubMed ID: 29291446
[TBL] [Abstract][Full Text] [Related]
14. Pyrrolotetrazinones deazaanalogues of temozolomide induce apoptosis in Jurkat cell line: involvement of tubulin polymerization inhibition.
Viola G; Cecconet L; Leszl A; Basso G; Brun P; Salvador A; Dall'Acqua F; Diana P; Barraja P; Cirrincione G
Cancer Chemother Pharmacol; 2009 Nov; 64(6):1235-51. PubMed ID: 19363609
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of pyrazole/isoxazole linked arylcinnamides as tubulin polymerization inhibitors and potential antiproliferative agents.
Kamal A; Shaik AB; Rao BB; Khan I; Bharath Kumar G; Jain N
Org Biomol Chem; 2015 Oct; 13(40):10162-78. PubMed ID: 26303171
[TBL] [Abstract][Full Text] [Related]
16. Investigation of anti-tumor mechanisms of K2154: characterization of tubulin isotypes, mitotic arrest and apoptotic machinery.
Lu PH; Kung FL; Kuo SC; Chueh SC; Guh JH
Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):223-33. PubMed ID: 17102938
[TBL] [Abstract][Full Text] [Related]
17. 6,7-Dimethoxy-3-(3-methoxyphenyl)isoquinolin-1-amine induces mitotic arrest and apoptotic cell death through the activation of spindle assembly checkpoint in human cervical cancer cells.
Chung KS; Choi HE; Shin JS; Cho YW; Choi JH; Cho WJ; Lee KT
Carcinogenesis; 2013 Aug; 34(8):1852-60. PubMed ID: 23615402
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of microtubule assembly in tumor cells by 3-bromoacetylamino benzoylurea, a new cancericidal compound.
Jiang JD; Wang Y; Roboz J; Strauchen J; Holland JF; Bekesi JG
Cancer Res; 1998 May; 58(10):2126-33. PubMed ID: 9605756
[TBL] [Abstract][Full Text] [Related]
19. Targeting of tubulin polymerization and induction of mitotic blockage by Methyl 2-(5-fluoro-2-hydroxyphenyl)-1H-benzo[d]imidazole-5-carboxylate (MBIC) in human cervical cancer HeLa cell.
Hasanpourghadi M; Karthikeyan C; Pandurangan AK; Looi CY; Trivedi P; Kobayashi K; Tanaka K; Wong WF; Mustafa MR
J Exp Clin Cancer Res; 2016 Mar; 35():58. PubMed ID: 27030360
[TBL] [Abstract][Full Text] [Related]
20. GS-164, a small synthetic compound, stimulates tubulin polymerization by a similar mechanism to that of Taxol.
Shintani Y; Tanaka T; Nozaki Y
Cancer Chemother Pharmacol; 1997; 40(6):513-20. PubMed ID: 9332466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
